Alvotech Net Income From Continuing Ops from 2010 to 2025

ALVO Stock  USD 11.82  0.05  0.42%   
Alvotech Net Loss yearly trend continues to be very stable with very little volatility. Net Loss is likely to grow to about -471.7 M this year. During the period from 2010 to 2025, Alvotech Net Loss quarterly data regression pattern had sample variance of 20321.2 T and median of (209,876,000). View All Fundamentals
 
Net Loss  
First Reported
2010-12-31
Previous Quarter
-496.6 M
Current Value
-471.7 M
Quarterly Volatility
142.6 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Alvotech financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Alvotech's main balance sheet or income statement drivers, such as Interest Income of 5.8 M, Depreciation And Amortization of 20.4 M or Interest Expense of 139.4 M, as well as many indicators such as Price To Sales Ratio of 33.56, Dividend Yield of 0.0 or Days Sales Outstanding of 282. Alvotech financial statements analysis is a perfect complement when working with Alvotech Valuation or Volatility modules.
  
Check out the analysis of Alvotech Correlation against competitors.
To learn how to invest in Alvotech Stock, please use our How to Invest in Alvotech guide.

Latest Alvotech's Net Income From Continuing Ops Growth Pattern

Below is the plot of the Net Income From Continuing Ops of Alvotech over the last few years. It is Alvotech's Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Alvotech's overall financial position and show how it may be relating to other accounts over time.
Net Income From Continuing Ops10 Years Trend
Slightly volatile
   Net Income From Continuing Ops   
       Timeline  

Alvotech Net Income From Continuing Ops Regression Statistics

Arithmetic Mean(275,244,182)
Geometric Mean246,840,801
Coefficient Of Variation(51.79)
Mean Deviation116,577,772
Median(209,876,000)
Standard Deviation142,552,466
Sample Variance20321.2T
Range450.2M
R-Value(0.65)
Mean Square Error12634.4T
R-Squared0.42
Significance0.01
Slope(19,398,017)
Total Sum of Squares304818.1T

Alvotech Net Income From Continuing Ops History

2025-471.7 M
2024-496.6 M
2023-551.7 M
2022-513.6 M
2021-101.5 M
2020-170 M

About Alvotech Financial Statements

Alvotech investors utilize fundamental indicators, such as Net Income From Continuing Ops, to predict how Alvotech Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Net Loss-496.6 M-471.7 M
When determining whether Alvotech offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Alvotech's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Alvotech Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Alvotech Stock:
Check out the analysis of Alvotech Correlation against competitors.
To learn how to invest in Alvotech Stock, please use our How to Invest in Alvotech guide.
You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Alvotech. If investors know Alvotech will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Alvotech listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.70)
Earnings Share
(1.84)
Revenue Per Share
1.557
Quarterly Revenue Growth
4.786
Return On Assets
(0.01)
The market value of Alvotech is measured differently than its book value, which is the value of Alvotech that is recorded on the company's balance sheet. Investors also form their own opinion of Alvotech's value that differs from its market value or its book value, called intrinsic value, which is Alvotech's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Alvotech's market value can be influenced by many factors that don't directly affect Alvotech's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Alvotech's value and its price as these two are different measures arrived at by different means. Investors typically determine if Alvotech is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Alvotech's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.